This image is not available for purchase in your country.

Herceptin drug and breast cancer cell

Herceptin drug and breast cancer cell

A617/0263

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

ALFRED PASIEKA / SCIENCE PHOTO LIBRARY ALFRED PASIEKA / SCIENCE PHOTO LIBRARY

Caption

Herceptin drug and breast cancer cell. Molecular model of Herceptin (Trastuzumab), showing the molecule's secondary structure, seen as alpha helices (coils) and beta sheets (arrows). A coloured scanning electron micrograph (SEM) of a breast cancer cell is at lower left (blue). Herceptin binds to HER2 (human epidermal growth factor receptor 2), a receptor that is over-expressed in some breast cancer cells, making them grow faster and more likely to spread. Herceptin blocks HER2, which kills the breast cancer cells. Around a fifth of breast cancers result from cells that over-express HER2, making them viable for Herceptin treatment.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}